BJC Reports

Welcome to BJC Reports

A partner journal to the British Journal of Cancer, one of the most cited oncology journals, BJC Reports is an open access journal focused on rapid publication and global reach.

Featured

Sustainability: a multifaceted important aspect of cancer care

Seamus O’Reilly
Catherine S. Weadick
Rachel J. Keogh
PerspectiveOpen Access08 Mar 2024
Climate change: why oncologists need to get involved

Joan H. Schiller
PerspectiveOpen Access08 Mar 2024
Weight, weight gain and behavioural risk factors in women attending a breast cancer family history, risk and prevention clinic: an observational study

Mary Pegington
John Belcher
Michelle Harvie
ArticleOpen Access14 Mar 2024
Racial and socioeconomic disparities in survival improvement of eight cancers

Vikram Shaw
Baoyi Zhang
Chao Cheng
ArticleOpen Access11 Mar 2024

Announcements

Sustainability in Oncology

We invite researchers, clinicians and experts to submit research articles, reviews, perspectives and editorials to our new section on Sustainability in Oncology.

Open for submissions
A Q&A with Deputy Editor Prof. Seamus O'Reilly

In this invited "SDG3 and Me" Q&A, Prof. Seamus O'Reilly discusses the National Green Cancer Clinical Trials initiative at Cancer Trials Ireland and its relevance to the UN's SDG3 and SDG13.
Application is open for our Editorial Board

If you are interested in joining the BJC Reports team as an Editorial Board member or Associate Editor, please complete this Google form. We will contact you if your expertise meets the needs of the journal.
Follow us on Twitter!

For journal updates, follow our Twitter account, @SN_Oncology, shared across Springer Nature's portfolio of open access and hybrid oncology journals.

Browse articles

Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors

M. R. Conroy
H. O’Sullivan
S. O’Reilly
ArticleOpen Access18 Apr 2024
Characterizing functional DNA damage and response caused by the combination of CHK1 and WEE1 inhibitors in ovarian and breast cancer models

Adam Stewart
Jiin Song
Udai Banerji
ArticleOpen Access03 Apr 2024
Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project

Masaki Shiota
Nobuaki Matsubara
Norio Nonomura
ArticleOpen Access03 Apr 2024
High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids

Kirti K. Iyer
Dennis Poel
Henk M. W. Verheul
ArticleOpen Access03 Apr 2024
Penetrance estimates of hereditary cancers in a population setting using UK Biobank data

Ranjit Manchanda
D. Gareth Evans
Adam Brentnall
Matters ArisingOpen Access15 Mar 2024
Response to Penetrance estimates of hereditary cancers in a population setting using UK Biobank data

Leigh Jackson
Michael N. Weedon
Caroline F. Wright
Matters ArisingOpen Access15 Mar 2024
Weight, weight gain and behavioural risk factors in women attending a breast cancer family history, risk and prevention clinic: an observational study

Mary Pegington
John Belcher
Michelle Harvie
ArticleOpen Access14 Mar 2024
Single cell atlas of kidney cancer endothelial cells reveals distinct expression profiles and phenotypes

Yuexin Xu
Chris P. Miller
Shreeram Akilesh
ArticleOpen Access14 Mar 2024
Racial and socioeconomic disparities in survival improvement of eight cancers

Vikram Shaw
Baoyi Zhang
Chao Cheng
ArticleOpen Access11 Mar 2024

Welcome to BJC Reports

Featured

Sustainability: a multifaceted important aspect of cancer care

Climate change: why oncologists need to get involved

Weight, weight gain and behavioural risk factors in women attending a breast cancer family history, risk and prevention clinic: an observational study

Racial and socioeconomic disparities in survival improvement of eight cancers

Announcements

Sustainability in Oncology

A Q&A with Deputy Editor Prof. Seamus O'Reilly

Application is open for our Editorial Board

Follow us on Twitter!

Browse articles

Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors

Characterizing functional DNA damage and response caused by the combination of CHK1 and WEE1 inhibitors in ovarian and breast cancer models

Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project

High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids

Penetrance estimates of hereditary cancers in a population setting using UK Biobank data

Response to Penetrance estimates of hereditary cancers in a population setting using UK Biobank data

Weight, weight gain and behavioural risk factors in women attending a breast cancer family history, risk and prevention clinic: an observational study

Single cell atlas of kidney cancer endothelial cells reveals distinct expression profiles and phenotypes

Racial and socioeconomic disparities in survival improvement of eight cancers

Trending - Altmetric

Search

Quick links

Featured

Announcements

Advertisement

Trending - Altmetric

High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids

Search

Quick links